Director of the Department of Neurology, Neurologist-in-chief
The Johns Hopkins Hospital
Dr. Justin McArthur received his medical degree from Guys Hospital Medical School at the University of London. He then completed an internship and residency in Internal Medicine at The Johns Hopkins Hospital. Dr. McArthur stayed at Johns Hopkins to complete a second residency in Neurology and to achieve a masters degree in public health.
Now a Professor of Neurology, Pathology, Medicine and Epidemiology, Dr. McArthur has become nationally and internationally recognized for his work in the epidemiology and treatment of HIV infection, multiple sclerosis, and other neurological infections and immune-mediated neurological disorders. He has been instrumental in the design and conduct of numerous clinical trials for these disorders. With Jack Griffin, he also developed a clinically-validated technique to use cutaneous nerves to study sensory neuropathies, including those associated with chemotherapy, HIV infection, and diabetes mellitus. He was recipient of the Department of Medicine Osler Housestaff Award in recognition of outstanding contributions to Housestaff teaching for four years, and the JHU Professor’s Award for Distinction in Teaching in the Clinical Sciences.
Dr. McArthur is currently the Director of the Department of Neurology at Johns Hopkins, and is also the Director of the Johns Hopkins/National Institute of Mental Health Research Center for Novel Therapeutics of HIV-associated Cognitive Disorders. The Center is comprised of an experienced interdisciplinary research team who have pooled their talents to study the nature of HIV-associated cognitive disorders. The aim is to translate discoveries of the pathophysiological mechanisms into novel therapeutics.
Creating a globally recognised centre of research collaboration excellence
Interactive Workshop: How to integrate patient care, research & teaching
Alan has a background which includes being a scientist, investment banker, entrepreneur and investor. Alan is currently very active in the Australian start-up space, investing in, advising and taking an active role within a number of early stage companies. Alan is currently the Executive Chairman at Clarity Pharmaceuticals, a company focused on developing radiopharmaceuticals for the treatment of cancer and other diseases. Alan is very focused on the commercialisation of new technologies, either in general technology or the life sciences.
Alan has approximately 10 years of investment banking experience, and was until recently an Executive Director and shareholder of Inteq Limited, a boutique Australian investment bank, where he remains on the Board of Directors. Alan has significant experience in capital raisings, mergers and acquisitions, and general corporate advisory. He has experience across a broad range of industries including healthcare and life sciences, technology, and resources.
Alan is a member of the Sydney Angels network, whose members invest in innovative early-stage companies with high growth potential. Alan is also a lecturer at the University of Sydney, lecturing to Masters of Commerce and International Business students undertaking studies in New Business Opportunities and Start-ups.
Alan completed an undergraduate degree in Applied Science at the University of Sydney, where he finished first in his year and won the prestigious University Medal. He completed his Ph.D. in Medicine at the Garvan Institute of Medical Research, where he investigated the molecular mechanisms of skeletal muscle insulin resistance. Alan has also completed a Graduate Diploma in Applied Finance at the Securities Institute of Australia.
PANEL DISCUSSION: Working together to ensure research excellence in order to attract commercial partners
Industry leading the change to collaboration
From 1 January 2015, the Government is planning to establish a Medical Research Future Fund. The Fund aims to help Australia to maintain a world class medical research sector.
Currently Australia has one of the most fragmented health systems in the world and is driven by many different funding agencies. Despite advances in basic research there are still considerable gaps in the acceleration of those findings into health and industry.
- Innovative funding & management models to drive excellence
- How to share vision & resources to enhance impact
- How to accelerate research findings into healthcare & industry
- How to integrate healthcare & research
Dr Noel Chambers
Chief Executive Officer
National Foundation for Medical Research and Innovation
Professor Bryan Williams
Chief Executive Officer
Professor Jim McCluskey
Deputy Vice-Chancellor (Research)
University of Melbourne
Professor Terry Campbell
Senior Associate Dean of Medicine
University of New South Wales